Huijie Bian

Summary

Affiliation: Fourth Military Medical University
Country: China

Publications

  1. Zhong Y, Sun X, Zhang P, Qin X, Chen W, Guo Y, et al. Identification and localization of xylose-binding proteins as potential biomarkers for liver fibrosis/cirrhosis. Mol Biosyst. 2016;12:598-605 pubmed publisher
  2. Zhang Z, Jiang J, Wu X, Zhang M, Luo D, Zhang R, et al. Chimeric antigen receptor T cell targeting EGFRvIII for metastatic lung cancer therapy. Front Med. 2019;13:57-68 pubmed publisher
    ..Therefore, CAR-T targeting EGFRvIII is a potential therapeutic strategy in preventing recurrence and metastasis of lung cancer after surgery. ..
  3. Zhang R, Zhang Z, Liu Z, Wei D, Wu X, Bian H, et al. Adoptive cell transfer therapy for hepatocellular carcinoma. Front Med. 2019;13:3-11 pubmed publisher
    ..In this review, we summarized the current application of ACT, the challenges encountered by CAR-T technology in HCC treatment, and some possible strategies for the future direction of immunotherapeutic research. ..
  4. Shi W, Ju D, Li H, Yuan L, Cui J, Luo D, et al. CD147 Promotes CXCL1 Expression and Modulates Liver Fibrogenesis. Int J Mol Sci. 2018;19: pubmed publisher
    ..Inhibition of CD147 attenuates CCl?-induced liver fibrosis and inflammation. Therefore, administration of targeting CD147 could be a promising therapeutic strategy in liver fibrosis. ..
  5. Yang L, Jin L, Ke Y, Fan X, Zhang T, Zhang C, et al. E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis. J Invest Dermatol. 2018;138:2568-2577 pubmed publisher
    ..Our study demonstrated that targeting K17 ubiquitination may be a potential therapeutic approach by attenuating STAT3 signaling in psoriasis. ..
  6. Zhong Y, Zhang J, Yu H, Zhang J, Sun X, Chen W, et al. Characterization and sub-cellular localization of GalNAc-binding proteins isolated from human hepatic stellate cells. Biochem Biophys Res Commun. 2015;468:906-12 pubmed publisher
  7. Wei D, Li Q, Wang X, Wang Y, Xu J, Feng F, et al. Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice. J Exp Clin Cancer Res. 2015;34:153 pubmed publisher
    ..This study provides a new strategy of arming oncolytic NDV with therapeutic antibody to enhance anti-tumor efficacy of cancer therapy. ..
  8. Li Q, Wei D, Feng F, Wang X, Li C, Chen Z, et al. ?2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus. J Cancer Res Clin Oncol. 2017;143:2171-2181 pubmed publisher
    ..The study provides evidence of optimized therapeutic strategy in oncolytic virotherapy via partly defining ?2,6-sialylated receptor as a "cellular marker" for NDV. ..
  9. Wei D, Xu J, Liu X, Chen Z, Bian H. Fighting Cancer with Viruses: Oncolytic Virus Therapy in China. Hum Gene Ther. 2017;: pubmed publisher
    ..Here, we focus on the studies that carried out in China to show the past, present, and future of oncolytic virotherapy in China. ..